Iloperidone treatment mitigates the Juvenile Huntington's Disease phenotype possibly via Sigma-1 Receptor Modulation

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Mario Frezzini
DOI: 10.5281/zenodo.18869248
Cited by: 0

Abstract

Coordinates (PDB), simulation setups (TPR) and trajectory (XTC) files for each system described in this work used for MD simulations.

Fields of Study & Subjects

Genetic Neurodegenerative Diseases Pharmacological Receptor Mechanisms and Effects Alzheimer's disease research and treatments

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
4 March 2026
Language
EN